These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35661797)

  • 21. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy.
    Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B
    Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
    Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
    Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral delivery of pectin-chitosan hydrogels entrapping macrophage-targeted curcumin-loaded liposomes for the treatment of ulcerative colitis.
    Wu M; Ping H; Wang K; Ding H; Zhang M; Yang Z; Du Q
    Int J Pharm; 2023 Nov; 647():123510. PubMed ID: 37839497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine A-loaded colon-targeted oral nanomicelles self-assembly by galactosylated carboxymethyl chitosan for efficient ulcerative colitis therapy.
    Xiong M; Li Y; He H; Hao S; Fang P; Xu M; Chen Y; Chen Y; Yu S; Hu H
    Eur J Pharm Biopharm; 2023 Aug; 189():152-164. PubMed ID: 37336365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing stability and anti-inflammatory properties of curcumin in ulcerative colitis therapy using liposomes mediated colon-specific drug delivery system.
    Wang C; Han Z; Wu Y; Lu X; Tang X; Xiao J; Li N
    Food Chem Toxicol; 2021 May; 151():112123. PubMed ID: 33744379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of pH-Dependent Nanozymes with Oxygen Vacancies as the High-Efficient Reactive Oxygen Species Scavenger for Oral-Administrated Anti-Inflammatory Therapy.
    Zhao N; Yang FE; Zhao CY; Lv SW; Wang J; Liu JM; Wang S
    Adv Healthc Mater; 2021 Dec; 10(23):e2101618. PubMed ID: 34569192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease.
    Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
    Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.
    Bao M; Wang K; Li J; Li Y; Zhu H; Lu M; Zhang Y; Fan Q; Han L; Wang K; Wang D; Gao Y; Peng B; Ming Z; Liu W
    Acta Biomater; 2023 Apr; 161():250-264. PubMed ID: 36863680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.
    Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
    Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
    Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy.
    Vong LB; Mo J; Abrahamsson B; Nagasaki Y
    J Control Release; 2015 Jul; 210():19-25. PubMed ID: 25998050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrathin Hafnium Disulfide Atomic Crystals with ROS-Scavenging and Colon-Targeting Capabilities for Inflammatory Bowel Disease Treatment.
    Li R; Fan Y; Liu L; Ma H; Gong D; Miao Z; Wang H; Zha Z
    ACS Nano; 2022 Sep; 16(9):15026-15041. PubMed ID: 36037406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease.
    Li S; Xie A; Li H; Zou X; Zhang Q
    J Control Release; 2019 Dec; 316():66-78. PubMed ID: 31682913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis.
    Hou L; Gong F; Liu B; Yang X; Chen L; Li G; Gong Y; Liang C; Yang N; Shen X; Liu Z; Cheng L
    Theranostics; 2022; 12(8):3834-3846. PubMed ID: 35664066
    [No Abstract]   [Full Text] [Related]  

  • 35. ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment.
    Tan C; Fan H; Ding J; Han C; Guan Y; Zhu F; Wu H; Liu Y; Zhang W; Hou X; Tan S; Tang Q
    Mater Today Bio; 2022 Mar; 14():100246. PubMed ID: 35372817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
    Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F
    Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.
    Wang X; Yan J; Wang L; Pan D; Xu Y; Wang F; Sheng J; Li X; Yang M
    Theranostics; 2020; 10(23):10808-10822. PubMed ID: 32929381
    [No Abstract]   [Full Text] [Related]  

  • 39. Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery.
    He P; Tang B; Li Y; Zhang Y; Liu X; Guo X; Wang D; She P; Xiao C
    Int J Nanomedicine; 2021; 16():5053-5064. PubMed ID: 34349508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycatechol-Derived Mesoporous Polydopamine Nanoparticles for Combined ROS Scavenging and Gene Interference Therapy in Inflammatory Bowel Disease.
    Wang L; Wang Z; Pan Y; Chen S; Fan X; Li X; Chen G; Ma Y; Cai Y; Zhang J; Yang H; Xiao W; Yu M
    ACS Appl Mater Interfaces; 2022 May; 14(17):19975-19987. PubMed ID: 35442639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.